First Insulin Pen with Memory

It presents sophisticated technology and features a digital display that allows patients to record and review their last 16 insulin doses, including the priming doses. This is especially important for both patients and physicians when developing a diabetes treatment plan that utilizes accurate recording of mealtime doses.

The HumaPen Memoir was developed by Eli Lilly and Company (Indianapolis, IN, USA), in partnership with Battelle Medical Device Solutions (Columbus, OH, USA). The device is designed for use with Eli Lilly's Humalog (an insulin lispro injection of rDNA origin), the most-prescribed mealtime insulin in the United States.

"I see real advantages in a new tool such as Memoir that remembers recent insulin doses, including the priming doses. The daily routine of balancing meals and blood sugar readings with multiple insulin injections can be cumbersome and overwhelming for patients,” said Linda Siminerio, Ph.D., an assistant professor of medicine and executive director of the University of Pittsburgh Diabetes Institute (PA, USA). "Anything that helps simplify the management of this disease and puts patients in a better position to self-manage is beneficial.”


Related Links:
Eli Lilly and Company
Battelle Medical Device Solutions
University of Pittsburgh Diabetes Institute